Clinical Trial Update: Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial of pitavastatin in combination with venetoclax for chronic lymphocytic leukemia or acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia

Drugs mentioned

• Pitavastatin (Pitavastatin)
• Venetoclax (venetoclax)

Snippet

Sponsor: University of California, Irvine | Conditions: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED